Investment Summary Following a series of investment updates since my April publication on Avanos Medical, Inc. (NYSE:AVNS), there is still the potential to unlock...
Introduction Invitae (NYSE:NVTA) is a leading provider of genetic testing services, digital health solutions, and health data services. Their genetic tests cover various clinical...
Introduction It has been four years since I last discussed Bekaert (OTCPK:BEKSF) (OTCPK:BEKAY) and back in 2019 I argued that Bekaert was worth having...